2,851
edits
No edit summary |
|||
Line 21: | Line 21: | ||
# [[Nicotinamid Mononukleotid (NMN)|NMN (Nicotinamide Mononucleotide)]]: A precursor to NAD+ that, when supplemented, has shown potential in increasing NAD+ levels in various studies, mainly in animals. | # [[Nicotinamid Mononukleotid (NMN)|NMN (Nicotinamide Mononucleotide)]]: A precursor to NAD+ that, when supplemented, has shown potential in increasing NAD+ levels in various studies, mainly in animals. | ||
# [[Nicotinamide Riboside (NR)|NR (Nicotinamide Riboside)]]: Another NAD+ precursor that can elevate NAD+ levels in the body. | # [[Nicotinamide Riboside (NR)|NR (Nicotinamide Riboside)]]: Another NAD+ precursor that can elevate NAD+ levels in the body. | ||
# Caloric Restriction: It has been observed to enhance NAD+ levels and activate sirtuins. | # [[Caloric Restriction]]: It has been observed to enhance NAD+ levels and activate sirtuins. | ||
# NAD+ Infusions: Direct infusion of NAD+ is being explored as a method, although it's still in the early stages of research. | # NAD+ Infusions: Direct infusion of NAD+ is being explored as a method, although it's still in the early stages of research. | ||